Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin.

J Baselga; D Pfister; M R Cooper; R Cohen; B Burtness; M Bos; G D'Andrea; A Seidman; L Norton; K Gunnett

doi:10.1200/JCO.2000.18.4.904

Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin.

Identifier:nobleid.org/w1/20260515/8EC770B2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/8EC770B2.svg?ark=w1%2F20260515%2F8EC770B2)](https://nobleid.org/work/w1/20260515/8EC770B2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin.

Identifier:nobleid.org/w1/20260515/8EC770B2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/8EC770B2.svg?ark=w1%2F20260515%2F8EC770B2)](https://nobleid.org/work/w1/20260515/8EC770B2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work